|
EP2364734B1
(en)
*
|
2000-07-21 |
2017-09-06 |
ReVance Therapeutics, Inc. |
Multi-component biological transport systems
|
|
US20040220100A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Essentia Biosystems, Inc. |
Multi-component biological transport systems
|
|
US6969514B2
(en)
|
2003-02-05 |
2005-11-29 |
Soll David B |
Method for treating elevated intraocular pressure, including glaucoma
|
|
CA2518265A1
(en)
|
2003-03-17 |
2004-09-30 |
Albany Molecular Research, Inc. |
Novel cyclosporins
|
|
ES2351976T3
(es)
*
|
2003-04-29 |
2011-02-14 |
Avi Biopharma, Inc. |
Composiciones para mejorar el transporte y la eficacia antisentido de análogos de ácidos nucleicos en células.
|
|
US8092788B2
(en)
*
|
2004-03-03 |
2012-01-10 |
Revance Therapeutics, Inc. |
Compositions and methods for topical diagnostic and therapeutic transport
|
|
PT2985039T
(pt)
|
2004-03-03 |
2018-11-09 |
Revance Therapeutics Inc |
Aplicação tópica e administração transdérmica de toxinas botulínicas
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
US20050288246A1
(en)
|
2004-05-24 |
2005-12-29 |
Iversen Patrick L |
Peptide conjugated, inosine-substituted antisense oligomer compound and method
|
|
GB0413613D0
(en)
*
|
2004-06-17 |
2004-07-21 |
Univ London |
Small molecule carriers
|
|
WO2006010084A2
(en)
*
|
2004-07-06 |
2006-01-26 |
Segev Laboratories Limited |
A system for delivering therapeutic agents into living cells and cell nuclei
|
|
US8680062B2
(en)
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
WO2006039163A2
(en)
|
2004-09-29 |
2006-04-13 |
Amr Technology, Inc. |
Cyclosporin alkyne analogues and their pharmaceutical uses
|
|
JP2008514702A
(ja)
|
2004-09-29 |
2008-05-08 |
エーエムアール テクノロジー インコーポレイテッド |
新規シクロスポリン類似体およびそれらの薬学的使用
|
|
WO2006041631A2
(en)
|
2004-10-06 |
2006-04-20 |
Amr Technology, Inc. |
Novel cyclosporin alkynes and their utility as pharmaceutical agents
|
|
US7442682B2
(en)
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
|
SG160357A1
(en)
|
2005-03-03 |
2010-04-29 |
Revance Therapeutics Inc |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
CN101160318A
(zh)
|
2005-03-03 |
2008-04-09 |
雷文斯治疗公司 |
用于局部施用和经皮肤递送寡肽的组合物和方法
|
|
GB2427360A
(en)
*
|
2005-06-22 |
2006-12-27 |
Complex Biosystems Gmbh |
Aliphatic prodrug linker
|
|
US8067571B2
(en)
|
2005-07-13 |
2011-11-29 |
Avi Biopharma, Inc. |
Antibacterial antisense oligonucleotide and method
|
|
WO2007038171A2
(en)
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Peptide nucleic acid based guanidinium compounds
|
|
US7745392B2
(en)
|
2005-09-23 |
2010-06-29 |
Nitto Denko Corporation |
Multi-valent guanidinium compounds for enhancing molecular translocation across cellular membranes and epithelial tissues
|
|
WO2007038172A2
(en)
*
|
2005-09-23 |
2007-04-05 |
Nitto Denko Corporation |
Guanidinium carriers
|
|
NZ568216A
(en)
*
|
2005-11-17 |
2012-09-28 |
Revance Therapeutics Inc |
Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
|
|
AU2006332523A1
(en)
*
|
2005-12-30 |
2007-07-12 |
Revance Therapeutics, Inc. |
Arginine heteromers for topical administration
|
|
US7696165B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
|
CA2655873C
(en)
|
2006-07-14 |
2017-10-17 |
Wisconsin Alumni Research Foundation |
Adsorptive membranes for trapping viruses
|
|
WO2008037463A2
(en)
*
|
2006-09-27 |
2008-04-03 |
Paolo Botti |
Means and methods of enhancing delivery to biological systems
|
|
EP1905454A1
(en)
*
|
2006-09-27 |
2008-04-02 |
Paolo Botti |
Formulations comprising cyclic compounds
|
|
NZ598159A
(en)
*
|
2006-12-29 |
2013-08-30 |
Revance Therapeutics Inc |
Transport molecules using reverse sequence hiv-tat polypeptides
|
|
CN101616682A
(zh)
*
|
2006-12-29 |
2009-12-30 |
雷文斯治疗公司 |
用源自hiv-tat的多肽片段稳定的肉毒杆菌毒素的组合物及其局部施用和透皮递送的方法
|
|
US9260476B2
(en)
|
2007-02-23 |
2016-02-16 |
The Research Foundation For The State University Of New York |
RNA targeting compounds and methods for making and using same
|
|
AU2008218939B2
(en)
*
|
2007-02-23 |
2014-05-08 |
The Research Foundation Of State University Of New York |
RNA targeting compounds and methods for making and using same
|
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
|
ES2516827T3
(es)
*
|
2007-04-23 |
2014-10-31 |
Deliversir Ltd |
Un sistema para entregar agentes terapéuticos a células vivas y núcleos de células
|
|
CA2691673A1
(en)
*
|
2007-06-29 |
2009-01-08 |
Avi Biopharma, Inc. |
Tissue specific peptide conjugates and methods
|
|
US20100016215A1
(en)
|
2007-06-29 |
2010-01-21 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
|
PL2178549T3
(pl)
*
|
2007-07-26 |
2017-03-31 |
Revance Therapeutics, Inc. |
Peptyd przeciwdrobnoustrojowy i jego kompozycje
|
|
US7842762B2
(en)
*
|
2007-08-08 |
2010-11-30 |
Ppg Industries Ohio, Inc. |
Electrodepositable coating composition containing a cyclic guanidine
|
|
WO2009099636A1
(en)
*
|
2008-02-07 |
2009-08-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Conjugation of small molecules to octaarginine transporters for overcoming multi-drug resistance
|
|
WO2010077732A2
(en)
*
|
2008-12-09 |
2010-07-08 |
Aether Medical Llc |
Implantable analgesic
|
|
US20100311671A1
(en)
*
|
2009-03-25 |
2010-12-09 |
Kai Pharmaceuticals |
Transdermal delivery of pkc modulatory peptides through microporated skin
|
|
US20110269665A1
(en)
|
2009-06-26 |
2011-11-03 |
Avi Biopharma, Inc. |
Compound and method for treating myotonic dystrophy
|
|
CA2797093C
(en)
|
2010-04-26 |
2019-10-29 |
Atyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase
|
|
EP2563381B1
(en)
|
2010-04-27 |
2017-08-09 |
aTyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl trna synthetases
|
|
CN103097524B
(zh)
|
2010-04-28 |
2016-08-03 |
Atyr医药公司 |
与丙氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
US9068177B2
(en)
|
2010-04-29 |
2015-06-30 |
Atyr Pharma, Inc |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
|
|
JP5991963B2
(ja)
|
2010-04-29 |
2016-09-14 |
エータイアー ファーマ， インコーポレイテッド |
バリルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
CN103097523B
(zh)
|
2010-04-29 |
2016-09-28 |
Atyr医药公司 |
与天冬酰胺酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
|
|
US8961961B2
(en)
|
2010-05-03 |
2015-02-24 |
a Tyr Pharma, Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
|
|
JP6008840B2
(ja)
|
2010-05-03 |
2016-10-19 |
エータイアー ファーマ， インコーポレイテッド |
フェニルアラニルαｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
JP6008841B2
(ja)
|
2010-05-03 |
2016-10-19 |
エータイアー ファーマ， インコーポレイテッド |
メチオニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
JP6008844B2
(ja)
|
2010-05-04 |
2016-10-19 |
エータイアー ファーマ， インコーポレイテッド |
ｐ３８ＭＵＬＴＩ−ｔＲＮＡ合成酵素複合体のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
JP6396656B2
(ja)
|
2010-05-14 |
2018-09-26 |
エータイアー ファーマ， インコーポレイテッド |
フェニルアラニルβｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
|
|
US8962560B2
(en)
|
2010-06-01 |
2015-02-24 |
Atyr Pharma Inc. |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Lysyl-tRNA synthetases
|
|
AU2011289831C1
(en)
|
2010-07-12 |
2017-06-15 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
|
|
AU2011293294B2
(en)
|
2010-08-25 |
2016-03-24 |
Pangu Biopharma Limited |
Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Tyrosyl-tRNA synthetases
|
|
US9161948B2
(en)
|
2011-05-05 |
2015-10-20 |
Sarepta Therapeutics, Inc. |
Peptide oligonucleotide conjugates
|
|
US9902957B2
(en)
|
2011-09-06 |
2018-02-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Amphipathic co-oligomers for the delivery of siRNA
|
|
US9816066B2
(en)
|
2012-04-24 |
2017-11-14 |
The Regents Of The University Of California |
Method for delivery of small molecules and proteins across the cell wall of algae using molecular transporters
|
|
CN102863357B
(zh)
*
|
2012-09-20 |
2014-01-01 |
华中农业大学 |
具有植物生长调节活性的化合物及其制备方法
|
|
CN104918639B
(zh)
|
2012-10-22 |
2018-01-26 |
萨拜格Rfa公司 |
用于将治疗剂递送到活细胞和细胞核中的系统
|
|
CA2889833A1
(en)
|
2012-10-28 |
2014-05-01 |
Revance Therapeutics, Inc. |
Compositions and methods for safe treatment of rhinitis
|
|
US9068089B2
(en)
|
2013-03-15 |
2015-06-30 |
Ppg Industries Ohio, Inc. |
Phenolic admix for electrodepositable coating composition containing a cyclic guanidine
|
|
US9688874B2
(en)
|
2013-10-25 |
2017-06-27 |
Ppg Industries Ohio, Inc. |
Method of making a bicyclic guanidine-cured acrylic coating
|
|
CN113861268B
(zh)
|
2014-05-21 |
2025-04-01 |
恩特拉达治疗学股份有限公司 |
细胞穿透肽及其制备和使用方法
|
|
US10815276B2
(en)
|
2014-05-21 |
2020-10-27 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
US10383912B2
(en)
*
|
2014-08-18 |
2019-08-20 |
Washington State University |
Tunable pH-sensitive linker for controlled drug release
|
|
EP3185880B1
(en)
|
2014-08-27 |
2020-02-12 |
Ohio State Innovation Foundation |
Improved peptidyl calcineurin inhibitors
|
|
US9854806B2
(en)
|
2015-05-19 |
2018-01-02 |
International Business Machines Corporation |
Antimicrobial guanidinium and thiouronium functionalized polymers
|
|
US11020417B2
(en)
|
2015-06-04 |
2021-06-01 |
Sarepta Therapeutics, Inc |
Methods and compounds for treatment of lymphocyte-related diseases and conditions
|
|
EP4613289A2
(en)
*
|
2016-07-27 |
2025-09-10 |
The Board of Trustees of the Leland Stanford Junior University |
Immolative cell-penetrating complexes for nucleic acid delivery
|
|
EP3554553B1
(en)
|
2016-12-19 |
2022-07-20 |
Sarepta Therapeutics, Inc. |
Exon skipping oligomer conjugates for muscular dystrophy
|
|
CA3063717C
(en)
|
2017-05-19 |
2021-08-24 |
Lunella Biotech, Inc. |
Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
|
|
US11339192B2
(en)
|
2017-10-04 |
2022-05-24 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitors
|
|
WO2019108729A1
(en)
|
2017-12-01 |
2019-06-06 |
Lunella Biotech, Inc. |
Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
|
|
EP3746105A4
(en)
|
2018-01-29 |
2022-05-18 |
Ohio State Innovation Foundation |
CYCLIC PEPTIDYLIN HIBITORS OF THE CAL-PDZ-BINDING DOMAIN
|
|
WO2019148194A2
(en)
|
2018-01-29 |
2019-08-01 |
Ohio State Innovation Foundation |
Peptidyl inhibitors of calcineurin-nfat interaction
|
|
TW201945014A
(zh)
|
2018-02-22 |
2019-12-01 |
美商安卓達治療股份有限公司 |
用於治療粒線體性神經胃腸腦病變之組合物及方法
|
|
CN119220109A
(zh)
|
2018-03-30 |
2024-12-31 |
贝克顿·迪金森公司 |
含侧基发色团的水溶性聚合染料
|
|
US11987647B2
(en)
|
2018-05-09 |
2024-05-21 |
Ohio State Innovation Foundation |
Cyclic cell-penetrating peptides with one or more hydrophobic residues
|
|
KR102167755B1
(ko)
|
2018-05-23 |
2020-10-19 |
주식회사 큐어바이오 |
단편화된 grs 폴리펩타이드, 이의 변이체 및 이들의 용도
|
|
WO2020069013A1
(en)
|
2018-09-27 |
2020-04-02 |
BioPhysics Pharma, Inc. |
Transdermal drug delivery system
|
|
US12246098B2
(en)
|
2018-09-27 |
2025-03-11 |
BioPhysics Pharma, Inc. |
Trans-epithelial membrane drug delivery system
|
|
US10953039B2
(en)
|
2018-09-27 |
2021-03-23 |
International Business Machines Corporation |
Utilizing polymers and antibiotics to enhance antimicrobial activity and inhibit antibiotic resistance
|
|
US11931416B2
(en)
|
2019-02-01 |
2024-03-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Immolative cell-penetrating complexes for nucleic acid delivery to the lung
|
|
TWI775313B
(zh)
|
2020-02-18 |
2022-08-21 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
CA3171648A1
(en)
|
2020-02-18 |
2021-08-26 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
TWI883391B
(zh)
|
2020-02-18 |
2025-05-11 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
US20230257420A1
(en)
*
|
2020-07-02 |
2023-08-17 |
University Of Houston System |
Compounds for drug delivery across blood-brain barrier
|
|
KR20230113767A
(ko)
|
2020-11-24 |
2023-08-01 |
라이엘 이뮤노파마, 인크. |
재생 t 세포의 제조 방법, 이를 포함하는 조성물 및 이의 사용 방법
|
|
PL4323362T3
(pl)
|
2021-04-16 |
2025-08-18 |
Gilead Sciences, Inc. |
Sposoby wytwarzania karbanukleozydów z zastosowaniem amidów
|
|
AU2022328698B2
(en)
|
2021-08-18 |
2025-02-20 |
Gilead Sciences, Inc. |
Phospholipid compounds and methods of making and using the same
|
|
EP4155349A1
(en)
|
2021-09-24 |
2023-03-29 |
Becton, Dickinson and Company |
Water-soluble yellow green absorbing dyes
|